Illumina raises 2025 revenue and EPS guidance as clinical demand strengthens and multiomics acquisition advances Illumina raises 2025 revenue and EPS guidance as clinical demand strengthens and multiomics acquisition advances Post ContentilmnRead More You might also be interested in reading Autoliv CFO Fredrik Westin to resign. August 1, 2025 In Mainstream ← Previous post Next post →